Figure 1 (Image 01)
Gabapentin Capsule
Product Images NDC 85534-0003
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 85534-0003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hawaii Repack, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 02)
This text appears to present a graph or data comparing the mean pain scores between different doses of Gabapentin and a placebo over a period of 4 weeks. The graph likely shows the pain scores for each week for baseline, placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day. The evaluation may demonstrate the effectiveness of different doses of Gabapentin in managing pain over time.*
Figure 3 (Image 03)
The provided text seems to refer to a figure illustrating the proportion of responders (patients with a 50% or more reduction in pain score) in controlled post-herpetic neuralgia (PHN) studies. The chart shows results from Study 1 and Study 2, comparing the response rates across different treatment groups such as placebo, GBP 3600, GBP 1800, and GBP 2400. The statistical significance of the results is also indicated using p-values.*
Image-04 (Image 04)
Gabapentin Structural Formula (Image 05)
Image-09 (Image 09)
This text shows a chart with different values for a daily dose in milligrams. The values range from 0 to 1600 mg with corresponding symbols and text labels. The chart seems to be related to medication dosages or similar quantitative data.*
100 (Label 100mg)
300 (Label 300mg)
400 (Label 400mg)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
